The mounting evidence underscores the importance of AGR2 in cancer immunotherapy, particularly in hepatobiliary and pancreatic cancers, suggesting its potential as a valuable target for novel therapeutic approaches [12,16,19,20]. Here, AGR2 is linked to pancreatic neoplasm.